Author : United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee
Publisher :
Page : 484 pages
File Size : 48,89 MB
Release : 1988
Category : Cancer
ISBN :
Abstract: This hearing discusses proposals made FDA to permit disease-specific health claims on food labels. Statements from medical associations and government agencies examine the effect and legality of allowing disease-specific health claims on food labels.
Author : Institute of Medicine
Publisher : National Academies Press
Page : 180 pages
File Size : 21,75 MB
Release : 2012-01-30
Category : Medical
ISBN : 0309218233
During the past decade, tremendous growth has occurred in the use of nutrition symbols and rating systems designed to summarize key nutritional aspects and characteristics of food products. These symbols and the systems that underlie them have become known as front-of-package (FOP) nutrition rating systems and symbols, even though the symbols themselves can be found anywhere on the front of a food package or on a retail shelf tag. Though not regulated and inconsistent in format, content, and criteria, FOP systems and symbols have the potential to provide useful guidance to consumers as well as maximize effectiveness. As a result, Congress directed the Centers for Disease Control and Prevention (CDC) to undertake a study with the Institute of Medicine (IOM) to examine and provide recommendations regarding FOP nutrition rating systems and symbols. The study was completed in two phases. Phase I focused primarily on the nutrition criteria underlying FOP systems. Phase II builds on the results of Phase I while focusing on aspects related to consumer understanding and behavior related to the development of a standardized FOP system. Front-of-Package Nutrition Rating Systems and Symbols focuses on Phase II of the study. The report addresses the potential benefits of a single, standardized front-label food guidance system regulated by the Food and Drug Administration, assesses which icons are most effective with consumer audiences, and considers the systems/icons that best promote health and how to maximize their use.
Author : United States. Federal Trade Commission. Bureau of Consumer Protection
Publisher :
Page : 32 pages
File Size : 32,71 MB
Release : 1998
Category : Advertising
ISBN :
Author :
Publisher :
Page : 72 pages
File Size : 24,26 MB
Release : 1999
Category : Food
ISBN :
Author : United States. Food and Drug Administration
Publisher :
Page : 152 pages
File Size : 48,67 MB
Release : 1993
Category : Database design
ISBN :
Gives generic instructions for developing and preparing an acceptable data base when valid estimates of nutrient content and variation are not available for the food (single or mixed products) to be labeled. The purpose of the manual is to advise the food industry in developing nutrition labels for food products that must comply with the regulations and to assist health professionals in interpreting nutrition labels on food products.
Author : Committee on the Nutrition Components of Food Labeling
Publisher : National Academies
Page : 56 pages
File Size : 31,35 MB
Release : 1990-01-01
Category : Medical
ISBN :
Nutrition Labeling offers a thorough examination of current nutrition labeling practices and recommends ways to make food labeling information consistent with recent dietary recommendations from the U.S. Surgeon General and the National Research Council. The volume proposes implementing a food labeling reform program, addressing such key issues as requiring mandatory nutrition labeling on most packaged foods, expanding nutrition labeling to foods that do not currently provide this information, making federal requirements uniform between agencies, and updating the nutrient content and format of food labels.
Author : Institute of Medicine
Publisher : National Academies Press
Page : 335 pages
File Size : 11,11 MB
Release : 2010-06-25
Category : Medical
ISBN : 0309157277
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
Author : National Research Council
Publisher : National Academies Press
Page : 527 pages
File Size : 34,81 MB
Release : 2005-01-03
Category : Medical
ISBN : 0309091101
The growing consumer interest in health and fitness has expanded the market for a wide range of products, from yoga mats to the multiple dietary supplements now on the market. Supplements are popular, but are they safe? Many dietary supplements are probably safe when used as recommended. However, since 1994 when Congress decided that they should be regulated as if they were foods, they are assumed to be safe unless the Food and Drug Administration can demonstrate that they pose a significant risk to the consumer. But there are many types of products that qualify as dietary supplements, and the distinctions can become muddled and vague. Manufacturers are not legally required to provide specific information about safety before marketing their products. And the sales of supplements have been steadily increasingâ€"all together, the various types now bring in almost $16 billion per year. Given these confounding factors, what kind of information can the Food and Drug Administration use to effectively regulate dietary supplements? This book provides a framework for evaluating dietary supplement safety and protecting the health of consumers.
Author : United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee
Publisher :
Page : 532 pages
File Size : 33,14 MB
Release : 1990
Category : Advertising
ISBN :
Abstract: These hearings examine the federal government's failure to protect consumers from false and misleading health claims on food labels. A 1987 Food and Drug Administration proposal permitted explicit disease-prevention claims on food labels. This proposal has seriously weakened. FDA's abililty to challenge even what the agency believes are deceptive claims. Testimony is received from Office Management and Budget officials, FDA officials, two state attorney generals, and a representative of the center for Science in the Public Interest.
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 483 pages
File Size : 45,17 MB
Release : 2017-09-28
Category : Medical
ISBN : 0309459575
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
